Henry Oliver's "Second Act" blends biography with social science, profiling the lives of late bloomers to uncover what led to ...

The magazine’s Ethicist columnist on the curation of a book collection.

What's on the horizon for the life sciences industry? Robin Johnson, PharmD, Gene Therapy Submissions Lead, inSeption Group What unique challenges do gene therapy submissions face compared to ...

In this guest commentary, Caleb Appleton, a principal at Bison Ventures, offers up a framework biotech founders can use to determine whether they should market their platform to others, or leverage it ...

Dr. Sattva S. Neelapu discusses how the CAR-T therapy Yescarta impacts the quality of life of patients with R/R indolent non-Hodgkin lymphoma.

Challenge trials help researchers study immune responses. Skeptics still doubt the approach is worth the risks ...

Since the close of World War II, more than 115 people have died from encounters with unexploded ordnance in the North Sea—but ...

In an interview given prior to today’s shock decision to withdraw from the Masters, the defending champion reflects on his ...

Extreme positions lead Americans to ignore public-health warnings rather than heed them.

Species in Lake Victoria, Lake Titicaca, Sri Lanka’s Wet Zone and the Western Ghats of India are particularly vulnerable to ...

Jessie’s first and most important hack to keeping glucose level steady is to have a savory breakfast. “Science shows us that if you eat sugar in the morning, you’re going to have a big glucose spike, ...

Who needs dystopian political science fiction in Amerika today? Real time nonfiction feels dystopian enough. The other ...